Services
Share
Follow
Apply market insights to your strategic decision-making
PharmARC’s market assessment studies greatly enhance our customers’ understanding of new markets: the market; the direct and indirect competition; potential risks; and other challenges related to the customer’s future success.
Our situation analysis addresses specific questions with a customized and holistic approach. We help customers understand their market by leveraging market share analysis and patient pool estimation techniques to determine the size of the market. We undertake epidemiology studies and segmentation analysis to identify customer segments and the best way to target them. Through our in-depth study and detailed analysis, we provide you with strategic recommendations on launching your product or brand into a particular market backed by our extensive secondary analysis of multiple data sets.
We provide TPP testing, ATU studies, and Product Attribute Analysis to find more insights on prescribing behavior. Using Treatment Guidelines Analysis, TPP Testing, and Unmet Need analysis, we provide a clear understanding of patient flows to our customers. In addition, we offer competitive intelligence solutions to identify, track and monitor competition effectively.
Our market assesment studies are supported by our team of experts located globally, in each market. Our disease area experts and local market area experts provide first-hand and authentic insights through a wide range of data sets, enabling us to provide our customers with accurate and detailed insights towards a successful market entry strategy.
Emerging Markets
The role of emerging markets in the pharmaceutical industry is more relevant now than ever before. Markets such as India and China represent significant opportunities for growth because of their rapid economic expansion. Annual pharmaceutical sales in the emerging markets is expected to reach $400billion by 2020, equivalent to current sales in the U.S. and the top five European markets combined. We are uniquely positioned to help customers take advantage of emerging market opportunities.
Headquartered in an emerging market, we have experience in working across most therapeutic and functional areas. We have a strong information network of KOLs, distributors, primary market research agencies and key associations.
PharmARC weaves local market knowledge and experience with best practices, process standardization and technology innovation to deliver customized analytics solutions. Secondary sources, KOL interviews, patient pools from distinct public and private markets, and income demographics are some of the alternate sources of information that we use in data-poor markets in the Asia Pacific region.
